Onsdag 28 Oktober | 18:58:46 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

AroCell Q2 - First quarter with a positive cash flow

2024-08-21 15:26:00

Redeye is encouraged to see AroCell recording its first quarter with a positive cash flow, and the report solidifies our take on the coming quarters. We learn about a coming strategic overview that could entail an acquisition, but nothing concrete has been announced. We leave our base case intact and point to AroCell trading at undeservedly low EV/sales multiples.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/